Assembly Concurrent ResolutionChaptered/Signed
ACR 93: Aromatic L-Amino Acid Decarboxylase Deficiency Awareness Day.
What ACR 93 does, verified December 6, 2025
This measure designates October 23 as Aromatic L-amino acid decarboxylase deficiency awareness day to raise awareness about this rare genetic disorder. It aims to educate the public about the condition and its effects on individuals and their families. By designating a specific day for awareness, it is hoped to increase support and resources for those affected by this disorder.
Bill journey
✓IntroducedComplete
✓In CommitteeComplete
✓First Chamber FloorComplete
✓Second ChamberComplete
✓GovernorComplete
6ChapteredCurrent
Last action: Chaptered by Secretary of State - Res. Chapter 153, Statutes of 2025. (2025-07-17)Alert me
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions15 total · showing 5
| Jul. 24, 2025 | Chaptered by Secretary of State - Res. Chapter 153, Statutes of 2025. |
| Jul. 24, 2025 | Enrolled and filed with the Secretary of State at 1 p.m. |
| Jul. 17, 2025 | Adopted and to Assembly. (Ayes 35. Noes 0. Page 2138.) |
| Jul. 17, 2025 | In Assembly. Ordered to Engrossing and Enrolling. |
| Jul. 17, 2025 | Adopted and to Assembly. (Ayes 35. Noes 0.) |
Latest bill textChaptered version, July 24, 2025 · 368 words
Assembly Concurrent Resolution No. 93
CHAPTER 153
Relative to Aromatic L-Amino Acid Decarboxylase Deficiency Awareness Day.
[ Filed with Secretary of State July 24, 2025. ]
LEGISLATIVE COUNSEL'S DIGEST
ACR 93, Dixon. Aromatic L-Amino Acid Decarboxylase Deficiency Awareness Day.
This measure would designate October 23, 2025, as Aromatic L-Amino Acid Decarboxylase Deficiency Awareness Day.
WHEREAS, A rare disease is generally considered to be a disease that affects fewer than 200,000 people in the United States at any given time; and
WHEREAS, There are more than 6,800 rare diseases. Altogether, rare diseases affect an estimated 25,000,000 to 30,000,000, inclusive, Americans; and
WHEREAS, Some rare diseases are often severely debilitating, impacting not only the patients but their families and loved ones, and have no effective treatments; and
WHEREAS, Aromatic l-amino acid decarboxylase (AADC) deficiency is a life-limiting, severely debilitating genetic neurologic condition that significantly impacts a patient’s development, motor skills, growth, and cognitive and language skills; and
WHEREAS, AADC deficiency results from an inherited genetic disease where patients lack the AADC enzyme that is required to create dopamine. Without dopamine, patients will never achieve motor milestones like holding their heads up, sitting, or standing, develop the ability to communicate, or perform the most basic of life’s needs. Patients are diagnosed through genetic and other biochemical tests; and
WHEREAS, Patients suffering from AADC deficiency often have low muscle tone that is unexplained and not improving. There are also other symptoms, such as developmental delays and involuntary eye movements; and
WHEREAS, AADC deficiency is a rare genetic neurological disease, and there have been approximately 350 cases of AADC Deficiency reported worldwide; and
WHEREAS, Caregivers of patients with AADC deficiency face many challenges and are often responsible for the overall care of the patient; and
WHEREAS, The Legislature can raise awareness of AADC deficiency in the public and medical communities; now, therefore, be it
Resolved by the Assembly of the State of California, the Senate thereof concurring, That the Legislature designates October 23, 2025, as Aromatic L-Amino Acid Decarboxylase Deficiency Awareness Day and encourages Californians to become better informed about, and aware of, AADC deficiency; and be it further
Resolved, That the Chief Clerk of the Assembly transmit copies of this resolution to the author for appropriate distribution.
Text of ACR 93 as chaptered, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions